![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Eastman Chemical Co | NYSE:EMN | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.52 | 0.52% | 101.25 | 101.64 | 100.21 | 101.02 | 1,018,465 | 21:22:17 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15 (d)
of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of Principal Executive Offices) (Zip Code)
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
Trading |
Name of each exchange | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. | Other Events |
On July 29, 2024, Eastman Chemical Company (the “Company”) issued a press release announcing that it commenced a cash tender offer (the “Tender Offer”) to purchase up to $250 million aggregate principal amount of the Company’s 3.800% Notes due 2025 (the “Notes”). The Tender Offer is being conducted on the terms and conditions set forth in the offer to purchase dated July 29, 2024 (the “Offer to Purchase”). The Tender Offer will expire at 5:00 p.m., New York City time, on August 26, 2024, unless extended or earlier terminated by the Company.
The Tender Offer is conditioned on the Company’s completion of an offering and sale of new debt securities on terms acceptable to the Company and on the other general conditions described in the Offer to Purchase.
A copy of the Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in Item 8.01 of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 is for informational purposes only and does not constitute an offer to purchase the Notes. The Tender Offer is not being made to holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction.
Item 9.01. | Financial Statements and Exhibits |
(d) Exhibits
Number |
Exhibit | |
99.1 | Press release dated July 29, 2024 | |
104 | Cover Page Interactive Data File (embedded with the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EASTMAN CHEMICAL COMPANY | ||||||
Date: July 29, 2024 | By: | /s/ Kevin Wang | ||||
Kevin Wang Vice President and Treasurer |
Exhibit 99.1
Eastman Chemical Company Announces Cash Tender Offer to Purchase Up to an Aggregate Principal Amount of $250 Million of its Outstanding 3.800% Notes due 2025
KINGSPORT, Tenn., July 29, 2024 Eastman Chemical Company (the Company or Eastman) (NYSE:EMN) today announced that it has commenced a cash tender offer (the Tender Offer) to purchase up to an aggregate principal amount of $250 million (the Tender Cap) of its outstanding 3.800% Notes due 2025 (the Notes). A comprehensive description of the terms of the Tender Offer is included in the Companys Offer to Purchase, dated July 29, 2024 (the Offer to Purchase).
The Tender Offer is being made upon, and is subject to, the terms and conditions set forth in the Offer to Purchase. The following table sets forth some of the terms of the Tender Offer.
Title of Security |
CUSIP / ISIN Number |
Principal Amount Outstanding |
Tender Cap (Principal Amount) |
U.S. Reference Treasury Security |
Bloomberg Reference Page(1) |
Fixed Spread (basis points) |
Early Tender Premium(2) (per $1,000) |
|||||||||||||||||||
3.800% notes due 2025 |
|
277432AR1 / US277432AR19 |
|
$ | 699,992,000 | $ | 250,000,000 | 1.750% UST due 03/15/2025 |
FIT3 | 22.5 bps | $ | 30 |
(1) | The applicable page on Bloomberg from which the Dealer Managers named below will quote the bid side price of the Reference Security (as defined below). In the above table, UST denotes a U.S. Treasury Security. | |
(2) | The Total Consideration (as defined below) for Notes validly tendered at or prior to the Early Tender Deadline (as defined below) and accepted for purchase will be calculated using the applicable Fixed Spread and is inclusive of the Early Tender Premium (as defined below). |
Details of the Tender Offer:
The Tender Offer will expire at 5:00 p.m., New York City time, on August 26, 2024, unless extended or earlier terminated by the Company (the Expiration Date). Holders of the Notes must validly tender their Notes at or prior to 5:00 p.m., New York City time, on August 9, 2024, unless extended (such date and time, as they may be extended, the Early Tender Deadline) in order to be eligible to receive the Total Consideration (as defined below), which includes the Early Tender Premium (as defined below). Any Notes tendered pursuant to the Tender Offer may be validly withdrawn at any time at or prior to 5:00 p.m., New York City time, on August 9, 2024 (such date and time, as they may be extended, the Withdrawal Deadline), but may not be withdrawn thereafter except in certain limited circumstances where additional withdrawal rights are required by law or if the Withdrawal Deadline is extended by the Company, in its sole discretion. No tenders will be valid if submitted after the Expiration Date.
The consideration paid in the Tender Offer for the Notes that are validly tendered and not validly withdrawn at or prior to the Early Tender Deadline and accepted for purchase will be determined in the manner described in the Offer to Purchase by reference to the fixed spread for the Notes specified in the table above and on the front cover of the Offer to Purchase plus the yield to maturity (the Reference Yield) based on the bid side price of the U.S. Treasury Reference Security specified in the table above and on the front cover of the Offer to Purchase (the Total Consideration), and includes an early tender premium of $30 per $1,000 principal amount of the Notes accepted for purchase (the Early Tender Premium). The term bid side price of the relevant Reference Security on any day means the bid side price of the applicable Reference Security as displayed on the Reference Page specified in the table above and on the cover of the Offer to Purchase as of 10:00 a.m., New York City time, on that day (or, if
the Dealer Managers (as named below) determine that the relevant page on Bloomberg is not operational or is displaying inaccurate information at that time, the bid side price of the applicable Reference Security will be determined at or around 10:00 a.m., New York City time, on that day by such other means as the Dealer Managers may consider to be appropriate under the circumstances). The Reference Yield will be determined at 10:00 a.m., New York City time, on August 12, 2024, unless extended by the Company (the Price Determination Date). Holders of the Notes who validly tender their Notes after the Early Tender Deadline but on or prior to the Expiration Date and whose Notes are accepted for purchase will receive the Total Consideration minus the Early Tender Premium (the Tender Offer Consideration). Payments for Notes purchased will include accrued and unpaid interest (rounded to the nearest cent) on such Notes from the last interest payment date up to, but not including, the Early Settlement Date (as defined below) or Final Settlement Date (as defined below), as applicable.
The Company reserves the right, subject to compliance with applicable law, to increase, decrease or eliminate the Tender Cap without extending the Early Tender Deadline, the Withdrawal Deadline or the Expiration Date, which could, in each case, result in the Company purchasing a greater or lesser aggregate principal amount of the Notes.
If the Tender Offer is not fully subscribed as of the Early Tender Deadline, subject to the Tender Cap, the Notes validly tendered and not validly withdrawn on or prior to the Early Tender Deadline will be accepted for purchase in priority to the Notes validly tendered following the Early Tender Deadline, subject to the satisfaction or waiver of all conditions of the Tender Offer. If the Tender Offer is fully subscribed as of the Early Tender Deadline, holders who validly tender their Notes after such Early Tender Deadline will not have any of their Notes accepted for payment. The Notes may be subject to proration if the aggregate principal amount validly tendered and not validly withdrawn is greater than the Tender Cap.
Payment for the Notes that are validly tendered prior to or at the Early Tender Deadline and that are accepted for purchase will be made promptly after the Early Tender Deadline (the Early Settlement Date). The Company anticipates that the Early Settlement Date will be August 14, 2024, the third business day following the Early Tender Deadline, unless extended by the Company and assuming all conditions of the Tender Offer have been satisfied or waived by the Company. Payment for the Notes that are validly tendered after the Early Tender Deadline but on or prior to the Expiration Date and that are accepted for purchase will be made promptly after the Expiration Date (the Final Settlement Date). The Company anticipates that the Final Settlement Date, if any, will be August 28, 2024.
The Tender Offer is not conditioned upon the tender of any minimum principal amount of the Notes. The Companys obligation to accept for purchase, and to pay for, the Notes validly tendered and not validly withdrawn pursuant to the Tender Offer is subject to and conditioned upon the satisfaction or waiver of a number of conditions described in the Offer to Purchase, including, among others, the Company completing an offering and sale of new debt securities on terms acceptable to the Company with proceeds sufficient to fund the Tender Offer.
The Company reserves the right, subject to applicable law, in its sole discretion, to (i) waive any and all conditions of the Tender Offer at any time and from time to time, (ii) extend or terminate the Tender Offer, (iii) increase, decrease or eliminate the Tender Cap without extending the Early Tender Deadline, Withdrawal Deadline or Expiration Date, or (iv) otherwise amend the Tender Offer in any respect.
The Notes that are validly tendered and accepted for purchase in the Tender Offer will be purchased by the Company and retired and canceled and will no longer remain outstanding obligations of the Company.
If a holder of the Notes does not tender its Notes or if a holder of the Notes tenders Notes that are not accepted for purchase, they will remain outstanding. If the Company consummates the Tender Offer, any existing trading market for any outstanding Notes may become more limited. For a discussion of this and other risks, see Risk Factors in the Offer to Purchase.
The Company has retained D.F. King & Co., Inc. as the tender agent and information agent (the Tender and Information Agent) for the Tender Offer. The Company has retained Barclays Capital Inc., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC as dealer managers (the Dealer Managers) for the Tender Offer.
For additional information regarding the terms of the Tender Offer, please contact: Barclays Capital Inc. at (800) 438-3242 (toll-free) or (212) 528-7581 (collect); J.P. Morgan Securities LLC at (866) 834-4666 (toll-free) or (212) 834-3554 (collect); or Morgan Stanley & Co. LLC at (800) 624-1808 (toll-free) or (212) 761-1057 (collect). Requests for documents and questions regarding the tendering of Notes may be directed to the Tender and Information Agent at (800) 967-4614 (toll-free), (212) 269-5550 (toll) or email at EMN@dfking.com.
THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT AN OFFER OR SOLICITATION TO PURCHASE NOTES. THE TENDER OFFER IS BEING MADE SOLELY PURSUANT TO THE OFFER TO PURCHASE, WHICH SETS FORTH THE COMPLETE TERMS OF THE TENDER OFFER THAT HOLDERS OF THE NOTES SHOULD CAREFULLY READ PRIOR TO MAKING ANY DECISION.
THE OFFER TO PURCHASE AND THIS PRESS RELEASE DO NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL NOTES IN ANY JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION IS UNLAWFUL. IN ANY JURISDICTION WHERE THE SECURITIES, BLUE SKY OR OTHER LAWS REQUIRE THE TENDER OFFER TO BE MADE BY A LICENSED BROKER OR DEALER, THE TENDER OFFER SHALL BE DEEMED TO BE MADE ON BEHALF OF THE COMPANY BY THE DEALER MANAGERS OR ONE OR MORE REGISTERED BROKERS OR DEALERS LICENSED UNDER THE LAWS OF SUCH JURISDICTION.
NONE OF THE COMPANY, THE DEALER MANAGERS, THE TENDER AND INFORMATION AGENT, OR THE TRUSTEE, NOR ANY OF THEIR RESPECTIVE AFFILIATES, IS MAKING ANY RECOMMENDATION AS TO WHETHER HOLDERS SHOULD TENDER NOTES IN RESPONSE TO THE TENDER OFFER. EACH HOLDER MUST MAKE HIS, HER OR ITS OWN DECISION AS TO WHETHER TO TENDER NOTES AND, IF SO, AS TO WHAT AGGREGATE PRINCIPAL AMOUNT OF NOTES TO TENDER. HOLDERS SHOULD CONSULT THEIR OWN TAX, ACCOUNTING, FINANCIAL AND LEGAL ADVISORS AS THEY DEEM APPROPRIATE REGARDING THE SUITABILITY OF THE TAX, ACCOUNTING, FINANCIAL AND LEGAL CONSEQUENCES OF PARTICIPATING OR DECLINING TO PARTICIPATE IN THE TENDER OFFER.
About Eastman Chemical Company
Founded in 1920, Eastman is a global specialty materials company that produces a broad range of products found in items people use every day. With the purpose of enhancing the quality of life in a material way, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. The Companys innovation-driven growth model takes advantage of world-class technology platforms, deep customer engagement, and differentiated application development to grow its leading positions in attractive end markets such as transportation, building and construction, and consumables. As a globally inclusive and diverse company, Eastman employs approximately 14,000 people around the world and serves customers in more than 100 countries. The Company had 2023 revenue of approximately $9.2 billion and is headquartered in Kingsport, Tennessee, USA.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act (Section 27A of the Securities Act of 1933, as amended and Section 21E of the Exchange Act). Forward- looking statements address a variety of subjects, including, for example, the terms and timing for completion of the Tender Offer, including the acceptance for purchase of any Notes validly tendered. Forward-looking statements are all statements, other than statements of historical fact, that may be made by the Company from
time to time. In some cases, you can identify forward-looking statements by terminology such as anticipates, believes, estimates, expects, intends, may, plans, projects, forecasts, will, would, could, and similar expressions, or expressions of the negative of these terms. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward-looking statements: the risks and uncertainties related to market conditions and satisfaction of customary closing conditions related to the completion of the Companys offering and sale of new debt securities and the risks and uncertainties described in the Offer to Purchase.
Forward-looking statements are based upon certain underlying assumptions as of the date such statements were made. Such assumptions are based upon internal estimates and other analyses of current market conditions and trends, management expectations, plans, and strategies, economic conditions, and other factors. Forward-looking statements and the assumptions underlying them are necessarily subject to risks and uncertainties inherent in projecting future conditions and results. Actual results could differ materially from expectations expressed in the forward-looking statements if one or more of the underlying assumptions and expectations proves to be inaccurate or is unrealized. The most significant known factors, risks, and uncertainties that could cause actual results to differ materially from those in the forward-looking statements are identified and discussed under Managements Discussion and Analysis of Financial Conditions and Risk Factors contained in the Companys Annual Report on Form 10-K for the year ended December 31, 2023 and the Companys Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024. Other factors, risks or uncertainties of which management is not aware, or presently deems immaterial, could also cause actual results to differ materially from those in the forward-looking statements.
Contacts
Media: Tracy Kilgore Addington
423-224-0498 / tracy@eastman.com
Investors: Greg Riddle
212-835-1620 / griddle@eastman.com
1 Year Eastman Chemical Chart |
1 Month Eastman Chemical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions